Timmers et al. [8] reported that BACE1 CSF levels showed strong correlations to all downstream AD markers, including Aβ1–40, Aβ1–42, and markers of neurodegeneration (total tau [t-tau] and phosphorylated tau [p-tau181p] proteins), in healthy elderly participants. Here, BACE1 is linked to Alzheimer disease.